ArticleFrontiers in oncology2020

Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma.

Zhonghua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.